Viewing Study NCT01452451


Ignite Creation Date: 2025-12-24 @ 11:52 PM
Ignite Modification Date: 2026-02-22 @ 8:26 AM
Study NCT ID: NCT01452451
Status: COMPLETED
Last Update Posted: 2016-08-09
First Post: 2011-10-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
Sponsor: Hanmi Pharmaceutical Company Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module